Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-094763
Filing Date
2020-08-13
Accepted
2020-08-13 17:11:19
Documents
59
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2020565d1_10q.htm 10-Q 862588
2 EXHIBIT 31.1 tm2020565d1_ex31-1.htm EX-31.1 10043
3 EXHIBIT 31.2 tm2020565d1_ex31-2.htm EX-31.2 10095
4 EXHIBIT 32.1 tm2020565d1_ex32-1.htm EX-32.1 6922
  Complete submission text file 0001104659-20-094763.txt   4344123

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nbse-20200630.xml EX-101.INS 1033763
6 XBRL TAXONOMY EXTENSION SCHEMA nbse-20200630.xsd EX-101.SCH 31185
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbse-20200630_cal.xml EX-101.CAL 40992
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbse-20200630_def.xml EX-101.DEF 61929
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbse-20200630_lab.xml EX-101.LAB 315545
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbse-20200630_pre.xml EX-101.PRE 220397
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 201100205
SIC: 2834 Pharmaceutical Preparations